Global Local
The renewed focus of MNC pharma companies on India promises to provide strong upside potential with low downside risks. MNC pharma companies, hitherto considered as safe bets rather than as strong contenders to domestic pharma players, are likely to see a total change in strategy. Saddled by stagnant growth in developed markets, lower returns on investments and higher R&D costs, MNC pharma companies are aggressively scouting for strong growth options. In their search for high growth-high potential markets, India, with its numerous growth triggers emerges as a strong destination. MNCs, after identifying India as their growth prescription, have embarked on a multi pronged strategy to establish their dominance in the Indian pharmaceutical market. Introduction of patented products, divesting non-core businesses, acquisitions, strengthening their sales & distribution network, developing India-centric strategies are a few of the steps taken by the MNCs to establish their stronghold in the Indian pharma market. Strong cash flows and healthy balance sheets, high dividend pay-outs, outperformance of the domestic market and strong patent product pipeline makes the Indian MNC pharma companies an attractive investment proposition.
| Reco | Company | CMP (Rs) | TP (Rs) |
| BUY | GlaxoSmithKline Pharma | 1103 | 1350 |
| BUY | Pfizer Ltd. | 730 | 867 |
--~--~---------~--~----~------------~-------~--~----~
Safe Harbor:
The information contained and provided on this Website provides Investment advice for the education of investors. The posts are an information service only. Recommendations, opinions or suggestions are given with the understanding that readers acting on this information assume all risks involved. We do not assume any responsibility or liability resulting from the use of such information, judgment and opinions for Trading or Investment purposes.
You received this message because you are subscribed to the Google Groups "Investors Please Listen !" group.
To post to this group, send email to investorspleaselisten@googlegroups.com
To unsubscribe from this group, send email to
investorspleaselisten+unsubscribe@googlegroups.com For more options, visit this group at http://groups.google.com/group/investorspleaselisten?hl=en
-~----------~----~----~----~------~----~------~--~---
No comments:
Post a Comment